Cigna Group $CI Stock Position Raised by Ballentine Partners LLC

Key Points

• Ballentine Partners LLC increased its position in Cigna Group by 18.4%, owning 9,429 shares valued at approximately $3.12 million.
• Cigna Group reported $7.20 EPS for the last quarter, exceeding analysts' expectations, with revenue of $67.13 billion, a 11% increase year-over-year.
• The company also declared a $1.51 quarterly dividend, resulting in an annual yield of 2.1% and a payout ratio of 32.97%.

Ballentine Partners LLC lifted its position in Cigna Group (NYSE:CI - Free Report) by 18.4% in the 2nd quarter, according to the company in its most recent filing with the SEC. The institutional investor owned 9,429 shares of the health services provider's stock after acquiring an additional 1,463 shares during the quarter. Ballentine Partners LLC's holdings in Cigna Group were worth $3,117,000 as of its most recent filing with the SEC.

Several other hedge funds have also made changes to their positions in the company. Flaharty Asset Management LLC acquired a new position in Cigna Group in the 1st quarter valued at approximately $28,000. 1248 Management LLC acquired a new position in Cigna Group in the 1st quarter valued at approximately $29,000. Activest Wealth Management increased its stake in Cigna Group by 360.0% in the 1st quarter. Activest Wealth Management now owns 92 shares of the health services provider's stock valued at $30,000 after buying an additional 72 shares during the period. Retirement Wealth Solutions LLC increased its stake in Cigna Group by 74.1% in the 2nd quarter. Retirement Wealth Solutions LLC now owns 101 shares of the health services provider's stock valued at $33,000 after buying an additional 43 shares during the period. Finally, Saudi Central Bank acquired a new position in Cigna Group in the 1st quarter valued at approximately $36,000. Hedge funds and other institutional investors own 86.99% of the company's stock.

Cigna Group Stock Performance

NYSE:CI opened at $291.61 on Thursday. Cigna Group has a 1 year low of $256.89 and a 1 year high of $358.88. The firm's fifty day simple moving average is $293.18 and its 200 day simple moving average is $311.02. The company has a current ratio of 0.71, a quick ratio of 0.71 and a debt-to-equity ratio of 0.65. The firm has a market capitalization of $77.84 billion, a PE ratio of 15.92, a PEG ratio of 0.85 and a beta of 0.48.

Cigna Group (NYSE:CI - Get Free Report) last posted its earnings results on Thursday, July 31st. The health services provider reported $7.20 earnings per share (EPS) for the quarter, beating analysts' consensus estimates of $7.15 by $0.05. Cigna Group had a net margin of 1.92% and a return on equity of 18.80%. The business had revenue of $67.13 billion for the quarter, compared to analyst estimates of $62.61 billion. During the same period last year, the business posted $6.72 EPS. Cigna Group's revenue was up 11.0% compared to the same quarter last year. Cigna Group has set its FY 2025 guidance at 29.600- EPS. On average, sell-side analysts anticipate that Cigna Group will post 29.77 EPS for the current year.

Cigna Group Announces Dividend

The business also recently declared a quarterly dividend, which was paid on Thursday, September 18th. Shareholders of record on Thursday, September 4th were issued a $1.51 dividend. The ex-dividend date of this dividend was Thursday, September 4th. This represents a $6.04 dividend on an annualized basis and a yield of 2.1%. Cigna Group's dividend payout ratio is 32.97%.

Insiders Place Their Bets

In other Cigna Group news, insider Nicole S. Jones sold 28,526 shares of the stock in a transaction on Friday, August 15th. The shares were sold at an average price of $300.00, for a total value of $8,557,800.00. Following the completion of the sale, the insider directly owned 25,648 shares of the company's stock, valued at $7,694,400. This represents a 52.66% decrease in their position. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is available at this link. 0.70% of the stock is currently owned by company insiders.

Analyst Upgrades and Downgrades

Several research analysts have weighed in on the stock. Guggenheim reiterated a "buy" rating and issued a $350.00 price objective (down previously from $388.00) on shares of Cigna Group in a research note on Monday, August 4th. TD Cowen upgraded shares of Cigna Group to a "strong-buy" rating in a research note on Monday, June 23rd. Truist Financial set a $375.00 price target on shares of Cigna Group in a research note on Tuesday, September 2nd. Robert W. Baird set a $372.00 price target on shares of Cigna Group in a research note on Thursday, August 14th. Finally, Deutsche Bank Aktiengesellschaft set a $415.00 price target on shares of Cigna Group and gave the stock a "buy" rating in a research note on Tuesday, August 5th. Two research analysts have rated the stock with a Strong Buy rating, fourteen have assigned a Buy rating and two have given a Hold rating to the company. According to MarketBeat, the company presently has a consensus rating of "Buy" and a consensus target price of $371.81.

About Cigna Group

The Cigna Group, together with its subsidiaries, provides insurance and related products and services in the United States. Its Evernorth Health Services segment provides a range of coordinated and point solution health services, including pharmacy benefits, home delivery pharmacy, specialty pharmacy, distribution, and care delivery and management solutions to health plans, employers, government organizations, and health care providers.

Want to see what other hedge funds are holding CI? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Cigna Group (NYSE:CI - Free Report).

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.